Introduction {#sec1}
============

N-heterocyclic aromatic scaffolds are often encountered in a wide range of compounds including natural products, pharmaceuticals, agrochemicals, and ligands.^[@ref1]^ Quinoline, a prominent structural scaffold, is found in a wide range of natural products and capable of showing diverse type of therapeutic activity.^[@ref2]^ Among them the 8-arylated quinoline moiety has its own importance as it is often found in bioactive compounds ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}).^[@ref3]^ Therefore, functionalization of the quinoline scaffold to corresponding 8-arylquinolines is highly desirable, in order to produce bioactive compounds synthetically.

![Selected Example of Bioactive 8-Arylquinoline Scaffolds](ao9b03884_0001){#sch1}

Transition metal-catalyzed regioselective C--H functionalization has emerged as an ideal strategy for the synthesis of therapeutically active quinoline scaffolds.^[@ref4]^ In this direction, N-oxide has been explored as an excellent directing group for the selective functionalization of quinolines.^[@cit4d],[@ref5]^ Although, C8 functionalization of quinoline *N*-oxides is not explored much,^[@ref6]^ various methods have been developed for C2 functionalization.^[@cit5a],[@cit5b],[@ref7]^ Among them, few reports are available on C8 arylation of quinolines ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}).^[@cit6a],[@cit6c],[@cit6d],[@cit6h]^ In 2011, first Rh(II)(NHC)-catalyzed direct C8 arylation of quinolines through C--H functionalization with aryl bromide as a coupling partner has been reported by the Chang group.^[@cit6a]^ Later, Pd(II)-catalyzed C8 arylation of quinoline *N*-oxide has been reported with aryl halide as a coupling partner by the Larionov group.^[@cit6c]^ In this direction, the Chang group also reported Ir(III)-catalyzed C8 arylation^[@cit6d]^ of quinoline *N*-oxide with aryldiazonium salt as an arylating source. In addition to these reports, the Liu group reported C8 arylation of quinoline *N*-oxide by using potassium aryltrifluoroborate as a coupling partner with a limited substrate scope and low yields. In spite of all these examples, cheaper metal, i.e., ruthenium has never been explored for C8 functionalization of quinoline *N*-oxides. Arylboronic acid is also most predominantly available and a cost-effective choice for arylation. Herein, we disclosed Ru(II)-catalyzed distal sp^2^(C8--H) arylation with arylboronic acids under mild reaction conditions ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}). During the compilation of this work, similar transformation was also reported by the Chang group,^[@ref8]^ but the current methodology is not limited only for quinoline *N*-oxide, it is also applicable for the arylation of indolines, 6-(5*H*)-phenanthridinone and *N*-*tert*-butylbenzamide substrates. Additionally, use of the Rh(III) catalyst in place of Ru(II), afforded an arylated product with N-oxide which provides opportunity for further derivatization ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}).

![Regioselective C8 Functionalization of Quinoline *N*-Oxide](ao9b03884_0002){#sch2}

Result and Discussion {#sec2}
=====================

Initially, quinoline *N*-oxide (**1a**) and arylboronic acid (**2a**) were reacted in the presence of \[RuCl~2~(*p*-cymene)\]~2~ (5 mol %), AgSbF~6~ (20 mol %), Cu(OTf)~2~ (20 mol %), Ag~2~CO~3~ (2.5 equiv), and dimethoxyethane (DME) as solvent at 100 °C under open air to afford 20% yield of the desired product (**3a**) along with quinoline (**4a**) as a side product ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 4). Therefore, we screened different silver additives and oxidants, in order to reduce undesired quinoline and we found that the combination of AgOTf, Cu(OTf)~2~, and Ag~2~O were appreciable to afford the arylated product and quinoline in a 70:30 ratio ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 9). Further optimization study shows that triflic anhydride (25 mol %) is also significant to carry out the reaction, which replaced costlier metal triflate salt, that is, AgOTf and Cu(OTf)~2~ without affecting the reaction yield ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 1). Additionally, triphenylboroxine (1 equiv) was found to be of approximately equal potency (entry 2). Solvent screening indicated tetrahydrofuran (THF) as a solvent of choice (entry 1, 4--5). Oxidant screening have shown Ag~2~O as the best one, while Ag~2~CO~3~, Cu~2~O, and Mn~2~O have shown inferior result than Ag~2~O ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 6--8). Alone Cu(OTf)~2~ as an additive with oxidant Ag~2~O gave 45% product yield ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 10). AgOTf instead of Tf~2~O was not able to give the product ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 11). Moreover, heat energy analysis indicated that the forward reaction is compatible broadly throughout 30--100 °C, but traces of the side product was also observed at 100 °C ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 12). Notably, we got rid of the undesired side reaction by performing the reaction at 40 °C instead of 100 °C. We have also tried other arylating agents such as trimethoxyphenylsilane (1 equiv AgF added additionally in order to make silane more reactive), triphenylborane, and tetraphenyltin, which afforded low to moderate yield of the desired product ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 3). We finalized the standard condition as 3 equiv phenylboronic acid, 5 mol % \[RuCl~2~(*p*-cymene)\]~2~, 25 mol % triflic anhydride, 2.5 equiv Ag~2~O, and THF as the solvent at 40 °C to afford 70% arylated product along with quinoline as a byproduct.

###### Optimization Study for Ru-Catalyzed C(8)--H Arylation[a](#t1fn1){ref-type="table-fn"}

![](ao9b03884_0007){#GRAPHIC-d7e419-autogenerated}

                                                                                                                        yield (%)[b](#t1fn2){ref-type="table-fn"}         
  ------------------------------------ -------------------------------------------------------------------------------- ------------------------------------------------- --------
  1                                    none                                                                             **70** (**60**)[e](#t1fn5){ref-type="table-fn"}   **30**
  2                                    triphenylboroxine instead of **2a**                                              70                                                30
  3                                    phenyltrimethoxysilane, triphenylborane, and tetraphenyltin instead of **2a**    upto 40                                            
  4[c](#t1fn3){ref-type="table-fn"}    DME as solvent along with AgSbF~6~ & Cu(OTf)~2~ salt and Ag~2~CO~3~ as oxidant   20                                                 
  5                                    1,4-dioxane instead of THF                                                       40                                                40
  6                                    Ag~2~CO~3~ instead of Ag~2~O                                                     40                                                 
  7                                    Cu~2~O instead of Ag~2~O                                                         25                                                 
  8                                    Mn~2~O instead of Ag~2~O                                                         10                                                 
  9                                    AgOTf and Cu(OTf)~2~ instead of Tf~2~O                                           70                                                30
  10                                   Cu(OTf)~2~ instead of Tf~2~O                                                     45                                                55
  11                                   AgOTf instead of Tf~2~O                                                          ND                                                 
  12                                   at 100 °C                                                                        45                                                35
  13[d](#t1fn4){ref-type="table-fn"}   \[RhCp\*Cl~2~\]~2~ instead of RuCl~2~(*p*-cymene)                                **92** (**90**)[e](#t1fn5){ref-type="table-fn"}    

Reaction condition: **1a** (0.1 mmol), **2a** (0.3 mmol), dry THF (0.5 mL), 40 °C, 16 h.

NMR Yield by using 1,1,2,2-tetrachloroethane as an internal standard.

At 100 °C.

Product with N-oxide.

Isolated yield, ND: not detected, Tf~2~O: trifluoromethanesulfonate anhydride, DME: dimethoxyethane, THF: tetrahydrofuran.

With the best optimized condition, substrate scopes with various arylboronic acids as well as quinoline *N*-oxide have been studied ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}). The reaction of C-2-substituted quinoline *N*-oxide **1b** and **1c** with **2a** afforded the corresponding C8 arylated products (**3b--3c**) in a good yield. On the other hand, electron deficient quinoline *N*-oxide (**1d** and **1i**) as well as polyaromatic quinoline *N*-oxide (**1j**) provided up to 28% desired product yield (**3d**, **3i--3j**). Variation of methyl at 4-position and 6-position gave a product yield of 32 and 28%, respectively (**3e** & **3f**), while 6-bromo quinoline *N*-oxide afforded 24% of the product yield (**3h**). Electron-rich quinoline *N*-oxide (**1g**) rings were able to give the product in 35% yield (**3g**). Next, differentially substituted arylboronic acids were tested with **1a** under optimal reaction conditions. Electron-rich arylating sources like 4-amylphenylboronic acid, 3,5-dimethylphenylboronic acid, 4-methylphenylboronic acid, and 4-methoxyphenylboronic acid were able to afford the corresponding arylated product in moderate to good yield (**3k**, **3l**, **3m**, **3o**), while the electron-deficient arylating source like 4-nitrophenylboronic acid gave no product. This indicates that nucleophilicity of the arylating source is significant; more nucleophilic arylating sources are good and vice-versa. Additionally, 4-chloro and 4-bromophenylboronic acids gave 52 and 35% yield, respectively (**3p** and **3q**), while 4-phenyl and 4-formylphenylboronic acid afforded 25 and 22% of product yield (**3n** and **3r**).

###### Substrate Scope of Ru-Catalyzed C--H Arylation[a](#t2fn1){ref-type="table-fn"}

![](ao9b03884_0008){#GRAPHIC-d7e781-autogenerated}

![](ao9b03884_0009){#gr7}

Reaction condition: **1** (0.4 mmol), **2** (1.2 mmol), \[RuCl~2~(*p*-cymene)\]~2~ (5 mol %), Ag~2~O (2.5 equiv), Tf~2~O (25 mol %), dry THF (2.0 mL) 40 °C, 16 h.

In order to investigate the standardized condition scope with other metal catalysts, we replaced Ru(II) metal with its isoelectronic species Rh(III) ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 13), which gave 90% isolated yield of 8-phenylquinoline *N*-oxide instead of the deoxygenated product (**3a**). With these re-optimized reaction conditions substrate scope was studied ([Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}). Halogenated quinoline *N*-oxide gave a good yield of the desired product (**5b**), and additionally electron-rich quinoline rings were twice better as compare to the electron-deficient ones (**5c** and **5d**). Moreover, 4-nitrophenylboronic acid was not compatible, possibly due to weaker nucleophilic arylating agent (**5i**). Besides this, 2-fluorophenylboronic acid was not able to give the product (**5j**), and it may be due to the steric factor as well as the fluoro group which is also the electron withdrawing group inductively, deteriorating its reactivity. Further, variation of meta and para-substituted phenylboronic acid gave up to 66% of the corresponding arylated product with N-oxide (**5e--5h**).

###### Scope of Rh(III)-Catalyzed C--H Arylation[a](#t3fn1){ref-type="table-fn"}

![](ao9b03884_0010){#GRAPHIC-d7e856-autogenerated}

![](ao9b03884_0011){#gr8}

Reaction condition: **1** (0.4 mmol), **2** (1.2 mmol), \[Cp\*RhCl~2~\]~2~ (5 mol %), Ag~2~O (2.5 equiv), Tf~2~O (25 mol %), dry THF (2.0 mL), 40 °C, 16 h.

Indoline scaffolds are also one of the most important bioactive structural moieties which are widely present in vinblastine, strychnine, and (−)-physostigmine.^[@ref9]^ There were also few reports for derivatization of the indoline scaffold in order to get more valuable bioactive products.^[@ref10]^

Therefore, we have tried to explore our arylation methodology for this important heterocyclic scaffolds with pyrimidine as the directing part, which can be removed easily by heating it at 110 °C in dimethyl sulfoxide solvent.^[@ref11]^ Interestingly, we got 90% corresponding C-7 arylated indoline product (**7a**) under slightly varied reaction conditions, that is, at 100 °C with an oxygen atmosphere. Subsequently, electronically different substituents at para and meta-position of phenylboronic acids were found to be well tolerated under revised reaction conditions and afforded a good yield of arylated products (7**b--**7**f**). We have also tried heteroarylation, as well as methylation by utilizing their corresponding boronic acid on indolines but it was found to be incompatible (**7g--7h**). Consequently, we have also explored arylation of benzo\[*h*\]quinoline and 6-(5*H*)-phenanthridinone with **2a**, which afforded 55 and 20% yield, respectively, at 100 °C with no oxygen atmosphere ([Table [4](#tbl4){ref-type="other"}](#tbl4){ref-type="other"}, entry **8** and **9**). In the same direction, the weak coordinating directing group-containing scaffold, that is, *N*-*tert*-butylbenzamide was reacted with **2a**, which gave 65% arylation on the ortho position of the amide group (**10**). These results show broad applicability of our developed methodology.

###### Scope of Ru(II)-Catalyzed Arylation of Indolines and Other Substrates[a](#t4fn1){ref-type="table-fn"}

![](ao9b03884_0012){#GRAPHIC-d7e944-autogenerated}

![](ao9b03884_0013){#gr9}

Reaction condition: **6** (0.4 mmol), **2** (1.2 mmol), \[RuCl~2~(*p*-cymene)\]~2~ (5 mol %), Ag~2~O (2.5 equiv), Tf~2~O (25 mol %), dry THF (2.0 mL), 100 °C, 20 h, O~2~ atmosphere for indoline substrates only.

In order to anticipate the mechanistic pathway, we have carried out control experiments. A parallel experiment showed that *K*~H~/*K*~D~ = 1.40 ([Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}.), which implies that the C--H bond cleavage might not be the rate limiting step.

![Parallel Experiment for KIE.](ao9b03884_0003){#sch3}

We have also tried to synthesize the ruthenacycle intermediate by the previously reported method^[@ref12]^ but we got quinoline oxygen coordinated ruthenium adduct **Ru1**, which have been characterized by NMR and single crystal X-ray diffraction technique ([Scheme [4](#sch4){ref-type="scheme"}](#sch4){ref-type="scheme"}a). Further, **Ru1** is utilized in place of an active ruthenium catalyst, which afforded the desired product in 50% yield ([Scheme [4](#sch4){ref-type="scheme"}](#sch4){ref-type="scheme"}b).

![Synthesis of the Ruthenium Adduct and Its Utility as an Catalyst.](ao9b03884_0004){#sch4}

No product was observed by reacting quinoline with **2a**, which confirmed the necessity of N-oxide as a directing part in the quinoline moiety ([Scheme [5](#sch5){ref-type="scheme"}](#sch5){ref-type="scheme"}a). In order to confirm the role of Ru as an deoxygenating agent, we have performed a preliminary experiment, one with the Ru(II) metal and second with the Rh(III) metal in the absence of **2a**, which afforded 35% yield of **4a** in the first case, while **1a** was intact in the second case ([Scheme [5](#sch5){ref-type="scheme"}](#sch5){ref-type="scheme"}b,c). In the same consequence, we have added 1 mol % of the Ru catalyst under Rh-catalyzed reaction conditions, which gave 48% arylated product **3a** ([Scheme [5](#sch5){ref-type="scheme"}](#sch5){ref-type="scheme"}d). These experiments strongly recommend the role of the Ru(II) metal as a deoxygenating agent along with catalytic activity in the same pot.

![Preliminary Experiment Showing Ru as a Deoxygenating Agent.](ao9b03884_0005){#sch5}

Further studies have shown that there is stronger bond dissociation energy in case of the Ru--O bond as compared to that of the Rh--O bond;^[@ref13]^ therefore, it can act as a driving force for the deoxygenation process in case of Ru-catalyzed reaction conditions.

On the basis of these preliminary experiments, we proposed the probable catalytic cycle ([Scheme [6](#sch6){ref-type="scheme"}](#sch6){ref-type="scheme"}). The reaction may proceed through the intermediacy of **Ru1** species, which may be formed through lewis acid (ruthenium metal) and lewis base (N-oxide) interaction, followed by C(8)--H activation leading to complex **B**, which can undergo transmetallation with arylboronic acid to afford complex **C**, which may oxidized to their higher valent metal complex **D**, in order to facilitate easy reductive elimination to afford product with N-oxide **5a**, which can be easily deoxygenated by the ruthenium catalyst in the same pot to afford the traceless product **3a**. Further, complex **E** can be oxidized to their active Ru species to continue the catalytic cycle.

![Proposed Mechanistic Pathway](ao9b03884_0006){#sch6}

Conclusions {#sec3}
===========

In conclusion, we have developed a new methodology for C8 arylation of quinoline *N*-oxide, with by utilizing Ru(II)-catalyst to afford deoxygenated arylated product in one pot. Moreover, we have also explored the Rh(III) catalyst, which afforded an arylated product with *N*-oxide. Additionally, we have also extended this methodology for other class of important heterocyclic scaffolds, indolines. Beside this, 6-(5*H*)-phenanthridinone and *N*-*tert*-butylbenzamide were also utilized for arylation. The role of the Ru metal as a deoxygenating agent was well explored which might be applied in future for other important application.

Experimental Section {#sec4}
====================

General Information {#sec4.1}
-------------------

All the reactions were carried out in screw cap reaction vials under an air atmosphere. All the solvents were bought from Aldrich in sure-seal bottle and used as such. Chemicals were bought from Sigma-Aldrich, Alfa Aesar, and TCI. For column chromatography, silica gel (230--400 mesh) and silica gel C18 from Merck was used. A gradient elution using *n*-hexane/ethyl acetate and MeOH/H~2~O was performed based on Merck aluminum TLC sheets (silica gel 60F~254~) and silica gel C18 on TLC plates.

Analytical Information {#sec4.2}
----------------------

The melting points were recorded on a Brønsted Electrothermal 9100. All isolated compounds are characterized by ^1^H NMR, ^13^C NMR, IR, and liquid chromatography (LC)/mass spectrometry (MS). In addition, all the compounds are further characterized by high-resolution mass spectrometry (HRMS). Mass spectra were recorded on Water Q-ToF-Micro Micromass, high-resolution 6560 Ion Mobility Q-TOF LC/MS (Agilent, Santa Clara,USA). IR was analyzed by Shimadzu IR Prestige-21 with a ZnSe Single reflection ATR accessory. Copies of ^1^H, ^13^C NMR, and ^19^F NMR are provided in [Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b03884/suppl_file/ao9b03884_si_001.pdf). Nuclear magnetic resonance spectra were recorded either on a Bruker-Avance 600 or 300 and 565 (^19^F NMR) MHz instrument. All ^1^H NMR experiments were reported in units, ppm and were measured relative to the signals for residual chloroform (7.24) and methanol (3.31 and 4.78) in the deuterated solvents. All ^13^C NMR spectra were reported in ppm relative to deuterated chloroform (77.23) and methanol (49.15) and all were obtained with ^1^H decoupling.

General Procedure for the Preparation of Quinoline *N*-Oxides^[@cit5a],[@ref14]^ {#sec4.3}
--------------------------------------------------------------------------------

All the solid reactants, *m*-CPBA (4 mmol) and quinoline (2 mmol) were added in a Schlenk tube and put under vacuum for 2 h, then CH~2~Cl~2~ (4 mL) was added at 0 °C. The reaction was allowed to stirred at room temperature for 12 h. On completion, the reaction mixture was extracted with ethyl acetate and the organic extract was dried over Na~2~SO~4~, filtered, and concentrated under reduced pressure. The crude product was purified by flash chromatography on silica gel (230--400 mesh size) with *n*-hexane/EtOAc to yield desired N-oxides.

General Procedure Preparation of **Ru1**([@ref8]) {#sec4.4}
-------------------------------------------------

Under an argon atmosphere, to an oven-dried reaction vial equipped with a magnetic stirring bar was added a solution of \[(*p*-cymene)RuCl~2~\]~2~ (60 mg, 0.1 mmol) in CH~2~Cl~2~ (1 mL), quinoline *N*-oxide (21.75 mg, 0.15 mmol), silver trifluoroacetate (44.17 mg, 0.2 mmol), and Li~2~CO~3~ (14.80 mg, 0.2 mmol). The reaction mixture was stirred at 25 °C for 12 h. An additional portion of silver trifluoroacetate (44.17 mg, 0.2 mmol) was added and the reaction mixture was further stirred at 25 °C for 12 h. The mixture was filtered through a pad of Celite and concentrated under reduced pressure. *n*-Hexane (1 mL) was added to the oily residue and the mixture was stirred for 16 h to form a yellow-green precipitant. After filtration, the filtrate was removed and the residue was dissolved in CH~2~Cl~2~ (2 mL), doped with *n*-hexane (3 mL), and the mixture was shaken to precipitate out the dark green chunk, which was removed by filtration through a pad of Celite. Slow evaporation of the filtrate at 25 °C provided the crude product as an orange crystal, which was further purified by recrystallization in CH~2~Cl~2~/*n*-hexane. Orange crystal (36.4 mg, 60%). ^1^H NMR (600 MHz, CDCl~3~): δ 8.54--8.58 (m, 2H), 8.14 (d, *J* = 8.4 Hz, 1H), 7.90--7.93 (m, 2H), 7.69--7.72 (m, 1H), 7.24--7.26 (m, 1H), 2.98--3.04 (m, 1H), 2.29 (s, 3H), 1.33 (d, *J* = 7.2 Hz, 6H). ^13^C NMR (150 MHz, CDCl~3~): δ 162.5, 143.4, 140.9, 135.4, 132.4, 129.8, 129.1, 128.4, 120.0, 119.1 114.92 (q, *J*~CF~ = 289.5 Hz), 99.7, 95.6, 79.8, 31.2, 22.5, 18.3. ^19^F NMR (565 MHz, CDCl~3~): δ −75.28.

General Procedure for C8 Arylation of Quinoline *N*-Oxides with Arylboronic Acids {#sec4.5}
---------------------------------------------------------------------------------

To an oven-dried screw cap reaction vial charged with a Spinvane magnetic stirbar, the starting material (0.4 mmol), arylboronic acid (1.2 mmol), \[Ru(*p*-cymene)Cl~2~\]~2~ (5 mol %), and silver oxide (2.5 equiv) were weighed, whereas liquid trifluoromethanesulfonate anhydride (25 mol %) were added by a micropipette and dry THF was added by a laboratory syringe, respectively. The reaction vial was closed with a screw cap and allowed to stir at 40 °C for 16 h. After completion, the reaction mixture was allowed to cool, filtered through a silica plug, and washed with CH~2~Cl~2~, followed by workup with aqueous NaHCO~3~ solution and CH~2~Cl~2~. The collected CH~2~Cl~2~ fraction of the crude reaction mixture was evaporated under reduced pressure. The residue was purified by flash chromatography using silica gel (230--400 mesh size) and *n*-hexane/EtOAc as an eluent. Note, \[RhCp\*Cl~2~\]~2~ was used instead of the Ru catalyst in order to get the arylated product with N-oxide.

Characterization Data {#sec4.6}
---------------------

### 8-Phenylquinoline ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}, Entry **3a**)^[@cit6a]^ {#sec4.6.1}

It was obtained as a light yellow liquid. Yield = 49.3 mg (60%). Isolated from flash chromatography (5% EtOAc/*n*-hexane). ^1^H NMR (600 MHz, CDCl~3~): δ 8.96--8.97 (m, 1H), 8.21 (dd, *J* = 7.8, 1.8 Hz, 1H), 7.84 (dd, *J* = 8.4, 1.2 Hz, 1H), 7.74 (dd, *J* = 7.2, 1.2 Hz, 1H), 7.70--7.72 (m, 2H), 7.60--7.63 (m, 1H), 7.51 (t, *J* = 7.8 Hz, 2H), 7.41--7.44 (m, 2H). ^13^C{^1^H} NMR (150 MHz, CDCl~3~): δ 150.4, 146.2, 141.1, 139.7, 136.4, 130.7, 130.5, 128.9, 128.1, 127.7, 127.5, 126.4, 121.1. HRMS (ESI-TOF) *m*/*z*: calcd for C~15~H~12~N \[M + H\]^+^, 206.0964; found, 206.0969.

### 7-Chloro-2-methyl-8-phenylquinoline ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}, Entry **3b**) {#sec4.6.2}

It was obtained as a light pale solid. Yield = 66.0 mg (65%), mp 125--127 °C. Isolated from flash chromatography (5% EtOAc/*n*-hexane). ^1^H NMR (600 MHz, CDCl~3~): δ 8.19 (d, *J* = 8.4 Hz, 1H), 7.84 (d, *J* = 8.4 Hz, 1H), 7.60 (d, *J* = 8.4 Hz, 1H), 7.44--7.46 (m, 2H), 7.40 (d, *J* = 7.2 Hz, 1H), 7.37 (d, *J* = 8.4 Hz, 1H), 7.30--7.31 (m, 2H), 2.54 (s, 3H). ^13^C{^1^H} NMR (150 MHz, CDCl~3~): δ 161.1, 147.9, 139.4, 138.0, 137.3, 135.2, 131.7, 129.2, 128.4, 128.2, 128.0, 126.6, 122.9, 24.88. IR (ZnSe) ν~max~ (cm^--1^): 1654, 1170, 1033, 763, 630. HRMS (ESI-TOF) *m*/*z*: calcd for C~16~H~13~ClN \[M + H\]^+^, 254.0731; found, 254.0732.

### 2,8-Diphenylquinoline ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}, Entry **3c**)^[@ref15]^ {#sec4.6.3}

It was obtained as a light yellow viscous liquid. Yield = 67.5 mg (60%). Isolated from flash chromatography (5% EtOAc/*n*-hexane). ^1^H NMR (600 MHz, CDCl~3~): δ 8.27 (d, *J* = 8.4 Hz, 1H), 8.18 (dd, *J* = 8.4, 1.2 Hz, 2H), 7.97 (d, *J* = 9.0 Hz, 1H), 7.88--7.89 (m, 2H), 7.80--7.84 (m, 2H), 7.60 (t, *J* = 7.8 Hz, 1H), 7.53--7.56 (m, 2H), 7.45--7.50 (m, 3H), 7.41--7.44 (m, 1H). ^13^C{^1^H} NMR (150 MHz, CDCl~3~): δ 156.3, 145.9, 141.1, 139.9, 139.8, 137.4, 131.5, 130.8, 129.6, 129.2, 129.1, 128.0, 127.9, 127.7, 127.5, 126.5, 118.4. HRMS (ESI-TOF) *m*/*z*: calcd for C~21~H~16~N \[M + H\]^+^, 282.1277; found, 282.1271.

### Methyl 8-Phenylquinoline-3-carboxylate ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}, Entry **3d**) {#sec4.6.4}

It was obtained as a red-brown solid, yield = 26.3 mg (25%), mp 118--120 °C. Isolated from flash chromatography (8% EtOAc/*n*-hexane). ^1^H NMR (300 MHz, CDCl~3~): δ 9.47 (d, *J* = 2.4 Hz, 1H), 8.89 (d, *J* = 2.4 Hz, 1H), 7.94 (dd, *J* = 7.4, 1.2 Hz, 1H), 7.85 (dd, *J* = 7.2, 1.8 Hz, 1H), 7.68--7.70 (m, 3H), 7.51 (t, *J* = 7.8 Hz, 2H), 7.42--7.45 (m, 1H), 4.02 (s, 3H).·^13^C{^1^H} NMR (75 MHz, CDCl~3~): δ 166.1, 149.9, 147.7, 141.2, 139.1, 139.1, 132.7, 130.7, 128.9, 128.2, 127.8, 127.5, 127.3, 123.0, 52.6. IR (ZnSe) ν~max~ (cm^--1^): 1722, 1614, 1433, 1263, 1219, 1099, 997, 777, 696. HRMS (ESI-TOF) *m*/*z*: calcd for C~17~H~14~NO~2~ \[M + H\]^+^, 264.1019; found, 264.1019.

### 4-Methyl-8-phenylquinoline ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}, Entry **3e**)^[@cit6a]^ {#sec4.6.5}

It was obtained as a brownish semisolid. Yield = 28.1 mg (32%). Isolated from flash chromatography (5% EtOAc/*n*-hexane). ^1^H NMR (300 MHz, CDCl~3~): δ 8.82 (d, *J* = 4.5 Hz, 1H), 8.03 (dd, *J* = 8.1, 1.5 Hz, 1H), 7.56--7.73 (m, 4H), 7.46--7.51 (m, 2H), 7.37--7.43 (m, 1H), 7.25--7.26 (m, 1H), 2.76 (s, 3H). ^13^C{^1^H} NMR (75 MHz, CDCl~3~) δ: 150.0, 145.8, 144.5, 141.6, 140.1, 130.8, 130.3, 128.9, 128.1, 127.4, 126.1, 123.6, 122.0, 19.3. HRMS (ESI-TOF) *m*/*z*: calcd for C~16~H~14~N \[M + H\]^+^, 220.1121; found, 220.1122.

### 6-Methyl-8-phenylquinoline ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}, Entry **3f**)^[@cit6a]^ {#sec4.6.6}

It was obtained as a whitish yellow semisolid. Yield = 24.6 mg (28%). Isolated from flash chromatography (5% EtOAc/*n*-hexane). ^1^H NMR (300 MHz, CDCl~3~): δ 8.88--8.89 (m, 1H), 8.10--8.13 (m, 1H), 7.69--7.72 (m, 2H), 7.58--7.59 (m, 2H), 7.49--7.52 (m, 2H), 7.35--7.44 (m, 2H), 2.58 (s, 3H). ^13^C{^1^H} NMR (75 MHz, CDCl~3~): δ 149.6, 144.9, 140.7, 139.8, 136.1, 135.7, 132.8, 130.7, 129.0, 128.1, 127.5, 126.5, 121.1, 21.7. HRMS (ESI-TOF) *m*/*z*: calcd for C~16~H~14~N \[M + H\]^+^, 220.1121; found, 220.1142.

### 6-Methoxy-8-phenylquinoline ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}, Entry **3g**)^[@cit6a]^ {#sec4.6.7}

It was obtained as a light yellow viscous semisolid. Yield = 32.9 mg (35%). Isolated from flash chromatography (5% EtOAc/*n*-hexane). ^1^H NMR (300 MHz, CDCl~3~): δ 8.80 (dd, *J* = 4.2, 1.8 Hz, 1H), 8.10 (dd, *J* = 8.4, 1.5 Hz, 1H), 7.77--7.70 (m, 2H), 7.35--7.53 (m, 5H), 7.10 (m, 1H), 3.97 (s, 3H). ^13^C{^1^H} NMR (75 MHz, CDCl~3~): δ 157.37, 149.1, 147.9, 142.6, 142.5, 139.2, 139.2, 130.7, 128.2, 127.7, 122.9, 121.4, 105.2, 55.7. HRMS (ESI-TOF) (*m*/*z*): calcd for C~16~H~14~NO \[M + H\]^+^, 236.1070; found, 236.1077.

### 6-Bromo-8-phenylquinoline ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}, Entry **3h**) {#sec4.6.8}

It was obtained as a white solid. Yield = 27.3 mg (24%). mp 71--72 °C. Isolated from flash chromatography (5% EtOAc/*n*-hexane). ^1^H NMR (600 MHz, CDCl~3~): δ 8.95 (dd, *J* = 4.2, 1.8 Hz, 1H), 8.12 (dd, *J* = 8.4, 1.8 Hz, 1H), 7.99 (d, *J* = 2.4 Hz, 1H), 7.83 (d, *J* = 1.8 Hz, 1H), 7.67--7.68 (m, 2H), 7.49--7.52 (m, 2H), 7.42--7.45 (m, 2H). ^13^C{^1^H} NMR (150 MHz, CDCl~3~): δ 150.5, 144.8, 142.9, 138.1, 135.3, 133.4, 130.6, 130.0, 129.3, 128.1, 128.0, 121.8, 120.1. IR (ZnSe) ν~max~ (cm^--1^): 3062, 3028, 1722, 1583, 1570, 1481, 854, 781, 754, 684. HRMS (ESI-TOF) *m*/*z*: calcd for C~15~H~11~BrN \[M + H\]^+^, 284.0069; found, 284.0061.

### 6-Nitro-8-phenylquinoline ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, Entry **3i**) {#sec4.6.9}

It was obtained as a yellow solid. Yield = 28.0 mg (28%). mp 150--152 °C. Isolated from flash chromatography (8% EtOAc/*n*-hexane). ^1^H NMR (600 MHz, CDCl~3~): δ 9.12 (dd, *J* = 4.2, 1.8 Hz, 1H), 8.78 (d, *J* = 2.4 Hz, 1H), 8.52 (d, *J* = 2.4 Hz, 1H), 8.41 (dd, *J* = 8.4, 1.8 Hz, 1H), 7.71--7.73 (m, 2H), 7.59 (dd, *J* = 8.4, 4.2 Hz, 1H), 7.55 (t, *J* = 7.8 Hz, 2H), 7.48--7.50 (m, 1H). ^13^C{^1^H} NMR (150 MHz, CDCl~3~): δ 153.4, 148.0, 145.1, 143.1, 138.2, 137.5, 130.5, 128.4, 128.2, 127.7, 123.6, 123.2, 122.6. IR (ZnSe) ν~max~ (cm^--1^): 2337, 1481, 1442, 1193, 1028, 783, 754, 686. HRMS (ESI-TOF) *m*/*z*: calcd for C~15~H~11~N~2~O~2~ \[M + H\]^+^, 251.0815; found, 251.0811.

### 5-Phenylbenzo\[*f*\]quinoline ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}, Entry **3j**)^[@cit6a]^ {#sec4.6.10}

It was obtained as a yellowish brown solid. Yield = 28.6 (28%). mp 100--102 °C. Isolated from flash chromatography (5% EtOAc/*n*-hexane). ^1^H NMR (600 MHz, CDCl~3~): δ 9.04 (dd, *J* = 8.4, 1.2 Hz, 1H), 9.00 (dd, *J* = 8.4, 1.8 Hz, 1H), 8.66 (d, *J* = 8.4 Hz, 1H), 8.01 (s, 1H), 7.96--7.98 (m, 1H), 7.76 (dd, *J* = 8.4, 1.2 Hz, 2H), 7.67--7.73 (m, 2H), 7.59 (dd, *J* = 8.4, 4.2 Hz, 1H), 7.53 (t, *J* = 7.8 Hz, 2H), 7.43--7.46 (m, 1H). ^13^C{^1^H} NMR (150 MHz, CDCl~3~): δ 149.56, 146.86, 139.85, 139.47, 131.59, 131.33, 130.96, 130.70, 129.65, 128.95, 128.14, 127.66, 127.59, 127.12, 125.94, 122.57, 121.28. HRMS (ESI-TOF) *m*/*z*: calcd for C~19~H~14~N \[M + H\]^+^, 256.1121; found, 256.1124.

### 8-(3,5-Dimethylphenyl)quinoline ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}, Entry **3k**) {#sec4.6.11}

It was obtained as a greenish viscous semisolid. Yield = 42.0 (45%). Isolated from flash chromatography (5% EtOAc/*n*-hexane). ^1^H NMR (600 MHz, CDCl~3~): δ 8.98 (dd, *J* = 4.2, 1.8 Hz, 1H), 8.20 (dd, *J* = 8.4, 1.8 Hz, 1H), 7.81 (dd, *J* = 8.4, 1.2 Hz, 1H), 7.70 (dd, *J* = 7.2, 1.8 Hz, 1H), 7.57--7.60 (m, 1H), 7.43 (dd, *J* = 8.4, 4.2 Hz, 1H), 7.27 (br s, 2H), 7.05 (s, 1H), 2.43 (s, 6H). ^13^C{^1^H} NMR (150 MHz, CDCl~3~): δ 150.4, 146.3, 141.5, 139.6, 137.5, 136.4, 130.4, 129.3, 128.8, 128.5, 127.4, 126.4, 121.0, 21.6. IR (ZnSe) ν~max~ (cm^--1^): 3059, 1722, 1604, 1481, 1265, 1193, 1028, 854, 783. HRMS (ESI-TOF) *m*/*z*: calcd for C~17~H~16~N \[M + H\]^+^, 234.1277; found, 234.1279.

### 8-(*p*-Tolyl)quinoline ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}, Entry **3l**)^[@cit6a]^ {#sec4.6.12}

It was obtained as a yellowish viscous liquid. Yield = 45.6 mg (52%). Isolated from flash chromatography (5% EtOAc/*n*-hexane). ^1^H NMR (600 MHz, CDCl~3~): δ 8.96 (dd, *J* = 4.2, 1.8 Hz, 1H), 8.19--8.21 (m, 1H), 7.81--7.82 (m, 1H), 7.73 (dd, *J* = 7.2, 1.2 Hz, 1H), 7.59--7.61 (m, 3H), 7.41 (dd, *J* = 8.4, 4.2 Hz, 1H), 7.32 (d, *J* = 7.8 Hz, 2H). ^13^C{^1^H} NMR (150 MHz, CDCl~3~): δ 150.6, 146.5, 141.3, 137.4, 137.0, 136.6, 130.8, 130.4, 129.12, 129.09, 127.6, 126.6, 121.3, 21.6. HRMS (ESI-TOF) *m*/*z*: calcd for C~16~H~14~N \[M + H\]^+^, 220.1121; found, 220.1119.

### 8-(4-Pentylphenyl)quinoline ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}, Entry **3m**) {#sec4.6.13}

It was obtained as a yellowish viscous liquid. Yield = 66.1 mg (60%). Isolated from flash chromatography (5% EtOAc/*n*-hexane). ^1^H NMR (600 MHz, CDCl~3~): δ 8.96 (dd, *J* = 4.2, 1.8 Hz, 1H) 8.20 (dd, *J* = 4.2, 1.8 Hz, 1H), 7.81 (dd, *J* = 7.8, 1.2 Hz, 1H), 7.74 (dd, *J* = 7.2, 1.2 Hz, 1H), 7.63 (d, *J* = 7.8 Hz, 2H), 7.58--7.61 (m, 1H), 7.41 (dd, *J* = 7.8, 4.2 Hz, 1H), 7.32 (d, *J* = 7.8 Hz, 2H), 2.69 (t, *J* = 7.8 Hz, 2H), 1.68--1.73 (m, 2H), 1.39--1.41 (m, 4H), 0.92--0.94 (m, 3H).·^13^C{^1^H} NMR (150 MHz, CDCl~3~): δ 150.2, 146.1, 142.1, 140.9, 136.8, 136.3, 130.5, 130.3, 128.8, 128.1, 127.3, 126.3, 120.9, 35.8, 31.7, 31.1, 22.6, 14.1. IR (ZnSe) ν~max~ (cm^--1^): 2926, 1571, 823, 792, 756. HRMS (ESI-TOF) *m*/*z*: calcd for C~20~H~22~N \[M + H\]^+^, 276.1747; found, 276.1746.

### 8-\[(1,1′Biphenyl-4-yl)quinoline ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}, Entry **3n**) {#sec4.6.14}

It was obtained as a white solid. Yield = 28.1 mg (25%). mp 155--157 °C. Isolated from flash chromatography (5% EtOAc/*n*-hexane). ^1^H NMR (300 MHz, CDCl~3~): δ 8.99 (dd, *J* = 4.2, 1.8 Hz, 1H), 8.23 (dd, *J* = 8.4, 1.8 Hz, 1H), 7.61--7.87 (m, 9H), 7.34--7.50 (m, 4H). ^13^C NMR (75 MHz, CDCl~3~): δ 150.5, 150.0, 141.3, 140.6, 140.4, 138.7, 136.5, 131.2, 130.5, 129.0, 128.9, 127.8, 127.7, 127.4, 127.0, 126.5, 121.2. IR (ZnSe) ν~max~ (cm^--1^): 1487, 1377, 825, 794, 761, 694. HRMS (ESI-TOF) *m*/*z*: calcd for C~21~H~16~N \[M + H\]^+^, 282.1277; found 282.1277.

### 8-(4-Methoxyphenyl)quinoline ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, Entry **3o**)^[@cit6a]^ {#sec4.6.15}

It was obtained as a white solid. Yield = 28.2 mg (30%). mp 109--110 °C. Isolated from flash chromatography (8% EtOAc/*n*-hexane). ^1^H NMR (300 MHz, CDCl~3~): δ 8.97 (dd, *J* = 4.2, 1.8 Hz, 1H), 8.20--8.23 (m, 1H), 7.80 (dd, *J* = 8.1, 1.5 Hz, 1H), 7.57--7.69 (m, 4H), 7.40--7.44 (m, 1H), 7.04--7.07 (m, 2H), 3.89 (s, 3H). ^13^C{^1^H} NMR (75 MHz, CDCl~3~): δ 159.3, 150.2, 146.1, 140.6, 136.6, 132.0, 131.9, 130.2, 129.0, 127.2, 126.5, 121.1, 113.8, 55.5. HRMS (ESI-TOF) *m*/*z*: calcd for C~16~H~14~NO \[M + H\]^+^, 236.1070; found, 236.1055.

### 8-(4-Chlorophenyl)quinoline ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, Entry **3p**) {#sec4.6.16}

It was obtained as a light brown solid. Yield = 49.9 mg (52%). mp 81--82 °C. Isolated from flash chromatography (5% EtOAc/*n*-hexane). ^1^H NMR (600 MHz, CDCl~3~): δ 8.96 (dd, *J* = 4.2, 1.8 Hz, 1H), 8.22 (dd, *J* = 8.4, 1.8 Hz, 1H), 7.85--7.86 (m, 1H), 7.72 (dd, *J* = 7.2, 1.2 Hz, 1H), 7.65 (d, *J* = 8.4 Hz, 2H), 7.60--7.63 (m, 1H), 7.47 (d, *J* = 8.4 Hz, 2H), 7.44 (m, 1H). ^13^C{^1^H} NMR (150 MHz, CDCl~3~): δ 150.3, 145.8, 139.6, 137.9, 136.3, 133.4, 131.8, 130.1, 128.7, 128.2, 127.8, 126.2, 121.1. IR (ZnSe) ν~max~ (cm^--1^): 1658, 1593, 1489, 1087, 817, 729. HRMS (ESI-TOF) *m*/*z*: calcd for C~15~H~11~ClN \[M + H\]^+^, 240.0575; found, 240.0574.

### 8-(4-Bromophenyl)quinoline ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}, Entry **3q**)^[@cit6c]^ {#sec4.6.17}

It was obtained as a bright white solid. Yield = 39.8 mg (35%). mp 70--72 °C. Isolated from flash chromatography (5% EtOAc/n-hexane). ^1^H NMR (300 MHz, CDCl~3~): δ 8.94--8.99 (m, 1H), 8.20--825 (m, 1H), 7.83--7.89 (m, 1H), 7.70--7.74 (m, 1H), 7.57--7.67 (m, 5H), 7.41--7.47 (m, 1H). ^13^C{^1^H} NMR (75 MHz, CDCl~3~): δ 150.5, 146.0, 139.8, 138.6, 136.5, 132.4, 131.3, 130.2, 128.9, 128.1, 126.4, 121.9, 121.3. HRMS (ESI-TOF) *m*/*z*: calcd for C~15~H~11~BrN \[M + H\]^+^, 284.0069; found, 284.0061.

### 8-(4-Formylphenyl)quinoline ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, Entry **3r**) {#sec4.6.18}

It was obtained as a red-brown solid. Yield = 20.5 mg (22%). mp 108--110 °C. Isolated from flash chromatography (5% EtOAc/*n*-hexane). ^1^H NMR (600 MHz, CDCl~3~): δ 10.10 (s, 1H), 8.96 (dd, *J* = 4.2, 1.8 Hz, 1H), 8.24 (dd, *J* = 8.4, 1.8 Hz, 1H), 8.01 (d, *J* = 8.4 Hz, 2H), 7.88--7.90 (m, 3H), 7.77 (dd, *J* = 7.2, 1.2 Hz, 1H), 7.64 (t, *J* = 7.8 1H), 7.46 (q, *J* = 4.2 Hz, 1H). ^13^C NMR (150 MHz, CDCl~3~): δ 192.4, 150.7, 146.2, 145.9, 139.7, 136.6, 135.4, 131.5, 130.6, 129.6, 128.9, 128.7, 126.4, 121.5. IR (ZnSe) ν~max~ (cm^--1^): 3051, 2922, 1660, 1593, 1489, 1463, 1381, 1087, 962, 817, 763, 729. HRMS (ESI-TOF) *m*/*z*: calcd for C~16~H~12~NO \[M + H\]^+^, 234.0913; found, 234.0911.

### 8-Phenylquinoline *N*-Oxide ([Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}, Entry **5a**)^[@cit6c]^ {#sec4.6.19}

It was obtained as a yellow semisolid. Yield = 79.7 mg (90%). Isolated from flash chromatography (95% EtOAc/*n*-hexane). ^1^H NMR (600 MHz, CDCl~3~): δ 8.37 (d, *J* = 5.4 Hz, 1H), 7.87 (d, *J* = 8.4 Hz, 1H), 7.78 (d, *J* = 8.4, 1H), 7.61 (t, *J* = 7.2, 1H), 7.53 (d, *J* = 7.2 Hz, 1H), 7.36--7.39 (m, 2H), 7.32--7.34 (m, 3H), 7.27--7.30 (m, 1H). ^13^C{^1^H} (150 MHz, CDCl~3~): δ 142.8, 139.2, 137.2, 136.5, 134.4, 132.1, 128.5, 128.2, 127.8, 127.0, 126.4, 126.3, 121.3. HRMS (ESI-TOF) *m*/*z*: calcd for C~15~H~12~NO \[M + H\]^+^, 222.0913; found, 222.0916.

### 6-Fluoro-8-phenylquinoline *N*-oxide ([Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}, Entry **5b**) {#sec4.6.20}

It was obtained as a yellowish viscous semisolid. Yield = 71.7 mg (75%). Isolated from flash chromatography (90% EtOAc/*n*-hexane). ^1^H NMR (600 MHz, CDCl~3~): δ 8.31 (d, *J* = 6.0 Hz, 1H), 7.70 (d, *J* = 8.4 Hz, 1H), 7.50 (dd, *J* = 7.8, 3.0 Hz, 1H), 7.35--7.40 (m, 3H), 7.30--7.32 (m, 4H). ^13^C{^1^H} NMR (150 MHz, CDCl~3~): δ 161.0, 159.4, 141.7, 139.9, 136.6, 133.3, 127.9, 127.2, 126.8, 125.6, 124.0, 122.4, 111.6. IR (ZnSe) ν~max~ (cm^--1^): 3055, 1511, 1325, 1276, 1159, 904, 763, 696, 638. HRMS (ESI-TOF) calcd for C~15~H~11~FNO \[M + H\]^+^, 240.0819; found, 240.0815.

### 6-Methoxy-8-phenylquinoline *N*-oxide ([Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}, Entry **5c**) {#sec4.6.21}

It was obtained as a yellow solid. Isolated Yield = 60.3 mg (60%). mp 52--54 °C. Isolated from flash chromatography (90% EtOAc/*n*-hexane). ^1^H NMR (600 MHz, CDCl~3~): δ 8.29 (dd, *J* = 6.0, 1.2 Hz, 1H), 7.72 (dd, *J* = 8.4, 1.2 Hz, 1H), 7.37--7.40 (m, 2H), 7.32--7.36 (m, 3H), 7.27--7.28 (m, 1H), 7.20 (d, *J* = 3.0 Hz, 1H), 7.16 (d, *J* = 2.4 Hz, 1H), 3.97 (s, 3H). ^13^C{^1^H} NMR (150 MHz, CDCl~3~): δ 158.0, 142.3, 138.3, 135.7, 135.0, 133.7, 128.1, 127.0, 126.5, 126.3, 121.7, 106.4, 102.4, 55.9. IR (ZnSe) ν~max~ (cm^--1^): 3325, 1606, 1575, 1365, 1328, 1207, 1174, 1028, 763. HRMS (ESI-TOF) calcd for C~16~H~14~NO~2~ \[M + H\]^+^, 252.1019; found, 252.1020.

### 6-Nitro-8-phenylquinoline *N*-oxide ([Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}, Entry **5d**) {#sec4.6.22}

It was obtained as a yellowish brown semisolid. Yield = 33.0 mg (31%). Isolated from flash chromatography (90% EtOAc/*n*-hexane). ^1^H NMR (600 MHz, CDCl~3~): δ 8.79 (d, *J* = 2.4 Hz, 1H), 8.46 (d, *J* = 6.0 Hz, 1H), 8.26 (d, *J* = 2.4 Hz, 1H), 7.92 (d, *J* = 8.4 Hz, 1H), 7.46 (dd, *J* = 8.4, 6.0 Hz, 1H), 7.38--7.44 (m, 3H), 7.33 (dd, *J* = 7.8, 1.8 Hz, 2H). ^13^C{^1^H} NMR (150 MHz, CDCl~3~): δ 145.79, 141.32, 140.84, 139.62, 139.47, 131.80, 127.94, 127.43, 127.33, 126.79, 124.32, 123.50, 102.40. IR (ZnSe) ν~max~ (cm^--1^): 3379, 1608, 1514, 1286, 1238, 1174, 1028, 823, 758. HRMS (ESI-TOF) calcd for C~15~H~11~N~2~O~3~ \[M + H\]^+^, 267.0764; found, 267.0769.

### 8-(4-Methoxyphenyl)quinoline *N*-oxide ([Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}, Entry **5e**) {#sec4.6.23}

It was obtained as a yellow solid. Yield = 66.3 mg (66%), mp 150--152 °C. Isolated from flash chromatography (95% EtOAc/*n*-hexane). ^1^H NMR (600 MHz, CDCl~3~): δ 8.36 (d, *J* = 6.0 Hz, 1H), 7.85 (d, *J* = 7.8 Hz, 1H), 7.75 (d, *J* = 8.4, 1H), 7.60 (t, *J* = 7.8 Hz, 1H), 7.53 (dd, *J* = 7.2, 1.8 Hz, 1H), 7.25--7.29 (m, 3H), 6.92 (d, *J* = 8.4 Hz, 2H), 3.86 (s, 3H). ^13^C NMR (150 MHz, CDCl~3~): δ 158.3, 139.5, 137.2, 136.3, 135.2, 134.6, 132.3, 129.4, 128.3, 127.8, 126.2, 121.2, 112.5, 55.4. IR (ZnSe) ν~max~ (cm^--1^): 2939, 2854, 1514, 1244, 1103, 1031, 823, 792, 758, 638. HRMS (ESI-TOF) *m*/*z*: calcd for C~16~H~14~NO~2~ \[M + H\]^+^, 252.1019; found, 252.1015.

### 8-(3,5-Dimethylphenyl)quinoline *N*-oxide ([Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}, Entry **5f**) {#sec4.6.24}

It was obtained as a light Yellow solid. Yield = 49.9 mg (50%), mp 64--65 °C. Isolated from flash chromatography (95% EtOAc/*n*-hexane). ^1^H NMR (600 MHz, CDCl~3~): δ 8.36 (d, *J* = 6.0 Hz, 1H), 7.85--7.86 (m, 1H), 7.76 (d, *J* = 8.4 Hz, 1H), 7.59 (m, 1H), 7.50 (dd, *J* = 7.2, 1.2 Hz, 1H), 7.26--7.29 (m, 1H), 6.97 (s, 1H), 6.94 (s, 2H), 2.36 (s, 6H). ^13^C{^1^H} NMR (150 MHz, CDCl~3~): δ 150.1, 142.8, 139.4, 137.1, 136.8, 136.3, 134.4, 132.1, 128.4, 128.1, 127.7, 126.1, 121.2, 21.6. IR (ZnSe) ν~max~ (cm^--1^): 2920, 2852, 1656, 1598, 1413, 1219, 1031, 819, 756. HRMS (ESI-TOF) *m*/*z*: calcd for C~17~H~16~NO \[M + H\]^+^, 250.1226; found, 250.1222.

### 8-(4-Bromophenyl)quinoline *N*-oxide ([Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}, Entry **5g**)^[@cit6d]^ {#sec4.6.25}

It was obtained as a brownish yellow solid. Yield = 60.99 mg (51%), mp 148--150 °C. Isolated from flash chromatography (90% EtOAc/*n*-hexane). ^1^H NMR (300 MHz, CDCl~3~): δ 8.36 (d, *J* = 6.0 Hz, 1H), 7.90 (dd, *J* = 8.1, 1.5 Hz, 1H), 7.77 (d, *J* = 8.1 Hz, 1H), 7.60--7.64 (m, 1H), 7.48--7.50 (m, 3H), 7.28--7.32 (m, 1H), 7.20 (d, *J* = 8.4 Hz, 2H). ^13^C{^1^H}NMR (75 MHz, CDCl~3~): δ 141.8, 139.2, 137.1, 135.3, 134.2, 132.2, 130.1, 129.9, 128.9, 127.8, 126.1, 121.5, 120.5. HRMS (ESI-TOF) *m*/*z*: calcd for C~15~H~11~BrNO \[M + H\]^+^, 300.0019; found, 300.0020.

### 8-(4-Trimethysilylphenyl)quinoline *N*-oxide ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, Entry **5h**) {#sec4.6.26}

It was obtained as a red-brown solid. Yield = 30.5 mg (26%), mp 60--62 °C. Isolated from flash chromatography (90% EtOAc/*n*-hexane). ^1^H NMR (600 MHz, CD~3~OD): δ 8.46 (d, *J* = 6 Hz, 1H), 8.17 (d, *J* = 8.4 Hz, 1H), 8.07 (m, *J* = 8.2, 1H), 7.73 (t *J* = 7.8, 1H), 7.59 (m, 1H), 7.54--7.51 (m, 1H), 7.49 (d, *J* = 7.8 Hz, 2H)., 7.26 (d, *J* = 7.8 Hz, 2H), 0.27 (s, 9H). ^13^C{^1^H} NMR (150 MHz, CD~3~OD): δ 144.5, 139.4, 138.7, 137.1, 136.7, 133.6, 132.9, 131.4, 130.1, 129.4, 128.9, 122.7, −1.0. IR (ZnSe) ν~max~ (cm^--1^): 2954, 2924, 1658, 1382, 1246, 835, 815, 758, 655. HRMS (ESI-TOF) *m*/*z*: calcd for C~18~H~20~NOSi \[M + H\]^+^, 294.1309; found, 294.1304.

General Procedure for Arylation of Indolines and Other Substrates with Arylboronic Acids {#sec4.7}
----------------------------------------------------------------------------------------

To an oven-dried screw cap reaction vial charged with a Spinvane magnetic stirbar, the starting material (0.4 mmol), arylboronic acid (1.2 mmol), \[Ru(*p*-cymene)Cl~2~\]~2~ (5 mol %), and silver oxide (2.5 equiv) were weighed, whereas liquid trifluoromethanesulfonate anhydride (25 mol %) were added by a micropipette and dry THF was added by a laboratory syringe, respectively. The reaction vial was closed with a screw cap and allowed to stir at 100 °C for 20 h. After completion, the reaction mixture was allowed to cool, filtered through a silica plug, and washed with CH~2~Cl~2~, followed by workup with aqueous NaHCO~3~ solution and CH~2~Cl~2~. The collected CH~2~Cl~2~ fraction of the crude reaction mixture was evaporated under reduced pressure. The residue was purified by flash chromatography using silica gel (230--400 mesh size) and *n*-hexane/EtOAc as an eluent. C~18~-reversed phase silica gel was required in case of the benzamide substrate by using MeOH and water as an eluent. An oxygen atmosphere is required only in the case of indoline substrates.

Characterization Data {#sec4.8}
---------------------

### 7-Phenyl-1-(pyrimidin-2-yl)indoline ([Table [4](#tbl4){ref-type="other"}](#tbl4){ref-type="other"}, Entry **7a**)^[@cit10f]^ {#sec4.8.1}

It was obtained as a yellow solid. Yield = 98.4 mg (90%), mp 90--91 °C. Isolated from flash chromatography (5% EtOAc/*n*-hexane). ^1^H NMR (300 MHz, CDCl~3~): δ 7.96 (d, *J* = 4.8 Hz, 2H), 7.33--7.36 (m, 2H), 7.24--7.30 (m, 2H), 7.10--7.19 (m, 4H), 6.38 (t, *J* = 4.8 Hz, 1H), 4.46 (m, 2H), 3.19 (m, 2H). ^13^C{^1^H} NMR (75 MHz, CDCl~3~): δ 159.3, 156.6, 142.4, 141.2, 135.1, 130.5, 129.1, 128.0, 126.8, 126.1, 123.9, 123.7, 111.9, 52.3, 29.7. HRMS (ESI-TOF) *m*/*z*: calcd for C~18~H~16~N~3~ \[M + H\]^+^, 274.1339; found, 274.1319.

### 7-(4-Chlorophenyl)-1-(pyrimidin-2-yl)indoline ([Table [4](#tbl4){ref-type="other"}](#tbl4){ref-type="other"}, Entry **7b**)^[@cit10f]^ {#sec4.8.2}

It was obtained as a oale solid. Yield = 61.5 (50%), mp 130--132 °C. Isolated from flash chromatography (5% EtOAc/*n*-hexane). ^1^H NMR (300 MHz, CDCl~3~): δ 8.04 (d, *J* = 4.8 Hz, 2H), 7.28--7.32 (m, 3H), 7.24 (dd, *J* = 7.8, 1.2 Hz, 1H), 7.13--7.17 (m, 3H), 6.48 (t, *J* = 4.8 Hz, 1H), 4.49 (m, 2H), 3.20 (t, *J* = 7.8 Hz, 2H). ^13^C{^1^H} NMR (75 MHz, CDCl~3~): δ 157.5, 156.7, 141.0, 140.9, 135.3, 132.0, 129.5, 128.9, 128.2, 128.2, 124.2, 124.1, 112.2, 52.5, 29.7. HRMS (ESI-TOF) *m*/*z*: calcd for C~18~H~15~ClN~3~ \[M + H\]^+^, 308.0949; found, 308.0950.

### 7-(4-Amylphenyl)-1-(pyrimidin-2-yl)indoline ([Table [4](#tbl4){ref-type="other"}](#tbl4){ref-type="other"}, Entry **7c**) {#sec4.8.3}

It was obtained as a light Yellow semisolid, yield 55.0 = (40%). Isolated from flash chromatography (7% EtOAc/*n*-hexane). ^1^H NMR (600 MHz, CDCl~3~): δ 7.95 (d, *J* = 4.8 Hz, 2H), 7.26--7.28 (m, 1H), 7.21--7.24 (m, 3H), 7.08--7.10 (m, 1H), 6.95 (d, *J* = 7.8 2H), 6.34 (t, *J* = 4.8 Hz, 1H), 4.44 (t, *J* = 7.8 Hz, 2H), 3.18 (t, *J* = 7.8 Hz, 2H), 2.50 (t, *J* = 7.8 Hz, 2H), 1.50--1.55 (m, 2H), 1.30--1.35 (m, 2H), 1.24--1.27 (m, 2H), 0.87--0.89 (m, 3H). ^13^C{^1^H} NMR (150 MHz, CDCl~3~): δ 156.9, 156.6, 141.2, 140.9, 139.6, 135.0, 130.5, 129.0, 128.1, 126.7, 123.8, 123.5, 111.8, 52.3, 35.6, 31.5, 31.4, 29.7, 22.7, 14.2. IR (ZnSe) ν~max~ (cm^--1^): 2924, 1573, 1548, 1452, 1429, 1379, 796. HRMS (ESI-TOF) *m*/*z*: calcd for C~23~H~26~N~3~ \[M + H\]^+^, 344.2121; found 344.2129.

### 7-(4-Cyanophenyl)-1-(pyrimidin-2-yl)indoline ([Table [4](#tbl4){ref-type="other"}](#tbl4){ref-type="other"}, Entry **7d**) {#sec4.8.4}

It was obtained as a yellow crystal. Yield = 41.8 mg (35%), mp 169--170 °C. Isolated from flash chromatography (5% EtOAc/*n*-hexane). ^1^H NMR (300 MHz, CDCl~3~): δ 7.98 (d, *J* = 4.8 Hz, 2H), 7.46 (s, 4H), 7.30 (m, 1H), 7.22--7.25 (m, 1H), 7.13 (t, *J* = 7.5 Hz, 1H), 6.45 (t, *J* = 4.8 Hz, 1H), 4.47 (t, *J* = 8.1 Hz, 2H), 3.19 (m, 2H). ^13^C{^1^H} NMR (75 MHz, CDCl~3~): δ 157.6, 156.8, 147.5, 141.3, 140.0, 135.5, 132.0, 128.72, 128.68, 127.5, 124.9, 124.1, 112.5, 109.6, 52.2, 29.5. IR (ZnSe) ν~max~ (cm^--1^): 2918, 2220, 1552, 1452, 1402, 786, 771, 738. HRMS (ESI-TOF) *m*/*z*: calcd for C~19~H~15~N~4~ \[M + H\]^+^, 299.1291; found, 299.1289.

### 7-(3,5-Dimethyl)phenyl)-1-(pyrimidin-2-yl)indoline ([Table [4](#tbl4){ref-type="other"}](#tbl4){ref-type="other"}, Entry **7e**)^[@cit10f]^ {#sec4.8.5}

It was obtained as a pale yellow solid. Yield = 60.3 mg (50%), mp 90--92 °C. Isolated from flash chromatography (5% EtOAc/*n*-hexane). ^1^H NMR (300 MHz, CDCl~3~): δ 7.97 (dd, *J* = 4.8, 1.2 Hz, 2H), 7.421--7.29 (m, 2H), 7.05--7.12 (m, 1H), 6.96 (s, 2H), 6.74 (s, 1H), 6.37--6.41 (m, 1H), 4.45 (m, 2H), 3.18 (t, *J* = 7.8 Hz, 2H), 2.17 (s, 6H). ^13^C{^1^H} NMR (75 MHz, CDCl~3~): δ 159.4, 156.5, 142.1, 141.2, 137.4, 134.9, 130.2, 129.0, 127.7, 124.7, 123.7, 123.6, 111.8, 52.3, 29.7, 21.2. HRMS (ESI-TOF) *m*/*z*: calcd for C~20~H~20~N~3~ \[M + H\]^+^, 302.1652; found, 302.1649.

### 7-(3,5-Bis(trifluoromethyl)phenyl)-1-(pyrimidin-2-yl)indoline ([Table [4](#tbl4){ref-type="other"}](#tbl4){ref-type="other"}, Entry **7f**) {#sec4.8.6}

It was obtained as a light yellow solid. Yield = 101.5 mg (62%), mp 78--79 °C. Isolated from flash chromatography (5% EtOAc/*n*-hexane). ^1^H NMR (600 MHz, CDCl~3~): δ 7.94 (d, *J* = 4.8 Hz, 2H), 7.78 (s, 2H), 7.61 (s, 1H), 7.33 (dd, *J* = 7.2, 6.0 Hz, 1H), 7.26--7.28 (m, 1H), 7.14--7.17 (m, 1H), 6.43 (t, *J* = 4.8 Hz, 1H), 4.48--4.51 (m, 2H), 3.22 (t, *J* = 7.8 Hz, 2H). ^13^C NMR (150 MHz, CDCl~3~): δ 158.9, 156.7, 144.8, 141.4, 135.7, 131.36 (q, *J*~CF~ = 33.0 Hz), 128.6, 127.3, 127.1, 125.2, 124.15, 123.43 (q, *J*~CF~ = 291.0 Hz), 119.54 (q, *J*~CF~ = 4.5 Hz), 112.46, 52.29, 29.43. ^19^F NMR (565 MHz, CDCl~3~): δ −62.87. IR (ZnSe) ν~max~ (cm^--1^): 1575, 1548, 1465, 1440, 1381, 1276, 1165, 1114, 1091, 798, 682. HRMS (ESI-TOF) *m*/*z*: calcd for C~20~H~14~F~6~N~3~ \[M + H\]^+^, 410.1086; found, 410.1086.

### 10-Phenylbenzo\[*h*\]quinoline ([Table [4](#tbl4){ref-type="other"}](#tbl4){ref-type="other"}, Entry **8**)^[@ref17]^ {#sec4.8.7}

It was obtained as a light yellow liquid. Yield = 56.2 mg (55%). Isolated from flash chromatography (5% EtOAc/*n*-hexane). ^1^H NMR (600 MHz, CDCl~3~): δ 8.45 (dd, *J* = 4.2, 1.8 Hz, 1H), 8.09 (dd, *J* = 8.4, 1.8 Hz, 1H), 7.94 (dd, *J* = 7.8, 1.2 Hz, 1H), 7.87 (d, *J* = 8.4 Hz, 1H), 7.69--7.71 (m, 2H), 7.58 (dd, *J* = 7.2, 1.8 Hz, 1H), 7.42--7.44 (m, 2H), 7.37--7.40 (m, 3H), 7.33 (dd, *J* = 7.8, 4.2 Hz, 1H). ^13^C{^1^H} NMR (150 MHz, CDCl~3~): δ 146.99, 146.95, 146.6, 141.8, 135.3, 135.1, 131.6, 129.2, 128.9, 128.4, 128.1, 127.5, 127.4, 127.2, 126.0, 125.8, 121.2. HRMS (ESI-TOF) *m*/*z*: calcd for C~19~H~14~N \[M + H\]^+^, 256.1121; found, 256.1132.

### 7-Phenylphenanthridin-6(5H)-one ([Table [4](#tbl4){ref-type="other"}](#tbl4){ref-type="other"}, Entry **9**) {#sec4.8.8}

It was obtained as a light yellow solid. Yield = 21.7 mg (20%). mp 265--266 °C. Isolated from flash chromatography (5% EtOAc/*n*-hexane). ^1^H NMR (300 MHz, CDCl~3~): δ 11.24 (br s, 1H, N**H**), 8.36 (d, *J* = 8.4 Hz, 1H), 8.23 (d, *J* = 8.1 Hz, 1H), 7.75--7.80 (m, 1H), 7.43--7.46 (m, 4H), 7.36--7.41 (m, 3H), 7.27--7.30 (m, 1H), 6.87 (d, *J* = 7.8 Hz, 1H). ^13^C{^1^H} NMR (75 MHz, CDCl~3~): δ 162.6, 145.4, 144.0, 136.5, 136.5, 131.7, 131.4, 129.6, 128.6, 127.5, 126.4, 123.2, 122.6, 121.9, 118.6, 116.6. IR (ZnSe) ν~max~ (cm^--1^): 3313, 1658, 1438, 1280, 1020. HRMS (ESI-TOF) *m*/*z*: calcd for C~19~H~14~NO \[M + H\]^+^, 272.1070; found, 272.1070.

### *N*-(*tert*-Butyl)-\[1,1′-biphenyl\]-2-carboxamide ([Table [4](#tbl4){ref-type="other"}](#tbl4){ref-type="other"}, Entry **10**)^[@ref18]^ {#sec4.8.9}

It was obtained as a whitish brown solid. Yield = 65.9 mg (65%), mp 97--100 °C. Isolated from manual column chromatography by using reverse phase C-18 silica (75% MeOH/H~2~O). ^1^H NMR (600 MHz, CDCl~3~): δ 7.72 (d, *J* = 7.8 Hz, 1H), 7.39--7.46 (m, 7H), 7.33 (d, *J* = 7.8 Hz, 1H), 5.00 (br s, 1H, N**H**), 1.10 (s, 9H). ^13^C NMR (150 MHz, CDCl~3~): δ 168.5, 140.6, 139.5, 136.9, 130.1, 129.9, 129.1, 129.0, 128.7, 127.8, 127.8, 51.5, 28.3. HRMS (ESI-TOF) *m*/*z*: calcd for C~17~H~20~NO \[M + H\]^+^, 254.1539; found, 254.1544.

Parallel Reaction for KIE Study {#sec4.9}
-------------------------------

In two different screw capped vials with a Spinvane triangular-shaped stirbar separately placed quinoline *N*-oxide (**1a**) (0.1 mmol) and C8-*d*~1~-quinoline *N*-oxide (**1a**-*d*~1~), (0.1 mmol) were reacted with arylboronic acid **2a** (3 equiv), \[Ru(*p*-cymene)Cl~2~\]~2~ (5 mol %), Tf~2~O (25 mol %), and Ag~2~O (2.5 equiv) in dry THF. Both the reaction mixtures were stirred at 40 °C for 5 h. Both the reactions mixtures were filtered through a silica plug and extracted with aqueous NaHCO~3~ and CH~2~Cl~2~. The organic phase was dried over Na~2~SO~4~ and removed under reduced pressure. Further, it has been isolated by flash chromatography and the analysis was performed on the basis of the isolated yield ([Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}).

**Ru1** as an Intermediate ([Scheme [4](#sch4){ref-type="scheme"}](#sch4){ref-type="scheme"}) {#sec4.10}
---------------------------------------------------------------------------------------------

To a screw capped vial with a Spinvane triangular-shaped stirbar quinoline *N*-oxide (0.1 mmol), arylboronic acid (3 equiv), **Ru1** (5 mol %), Tf~2~O (25 mol %), Ag~2~O (2.5 equiv), and dry THF were added. The reaction was stirred at 40 °C for 16 h. After completion, the reaction was filtered through a silica plug and extracted with aqueous NaHCO~3~ and CH~2~Cl~2~. The organic phase was dried over Na~2~SO~4~ and removed under reduced pressure for ^1^H NMR analysis by using 1,1,2,2-tetrachloroethane as an internal standard, which have shown 50% yield.

The Supporting Information is available free of charge at [https://pubs.acs.org/doi/10.1021/acsomega.9b03884](https://pubs.acs.org/doi/10.1021/acsomega.9b03884?goto=supporting-info).Optimization details and a copy of ^1^H and ^13^C NMR spectra for all synthesized compounds including X-ray data for **Ru1** ([PDF](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b03884/suppl_file/ao9b03884_si_001.pdf))
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